iris_edelstahlbau

IRIS - Solutions

Digital avoidance of faulty batches with IIOT!

Our wireless IRIS monitoring system is the perfect addition to our mobile stirring and mixing tanks, and is growing in popularity as one of our newest products.

IRIS is the solution for:

  • PROCESS OPTIMISATION
  • MAINTENANCE OPTIMISATION
  • LOGISTICS MANAGEMENT

IRIS includes access authorisation and an audit trail, thus it is suitable for use in the pharmaceutical industry.

WEB-BASED MULTIPARAMETER MONITORING PLATFORM
Browser-based, secure cloud & application

RECORD & MONITOR
Pressure & pressure gradient, load cycles, temperature, gradient level, condition, vibration…

WARNING AND ALARM NOTIFICATIONS
For configurable threshold values for pressure, temperature, speed etc.

DISCHARGE
Process optimisation, maintenance optimisation, safety optimisation

IoT SECURITY FROM PROCESSOR TO CLOUD

Edge device with secured processor

iris-wireless-monitoring-1

Managed OS and enclosed application

iris-wireless-monitoring-2

Secure communication via tunnel

iris-wireless-monitoring-3

Protected Cloud & application or server

All data is protected and encrypted
Traceability by saving processes from database access – audit trail

Visit IRIS website

Product groups from the wireless monitoring segment

iris-monitoring

Iris Monitoring System

IRIS Monitoring System for the data collection of tomorrow
to the articles
Request article group

Company

portfolio

links

Dear Sir or Madam,
Dear Mr Weinert,
27.04.2021


On April 30, 2021, we will open another site at Allergopharma GmbH & Co. KG in Reinbek to support COVID 19 vaccine production in the presence of Federal Minister Spahn and Minister President Günther. We would have been pleased to invite you to this opening.

Unfortunately, this was not possible due to the pandemic.
We would therefore like to take this opportunity to thank you for your extraordinary commitment to supplying equipment at short notice to support vaccine production. Allergopharma, as part of Dermapharm Holding SE, is now a further partner in the Europe-wide production network for the vaccine of BioNTech and Pfizer. This network now comprises more than a dozen important pharmaceutical manufacturers and suppliers. From now on, one of four production steps will take place in Reinbek: the vaccine formulation. This is where our mRNA active ingredient is combined with the lipids. A protective shell is created around the mRNA and the vaccine can reach its target in the body to induce the necessary immune response.


Your company has made a very important contribution to the global pandemic response with great know-how and under incredible time pressure. We would like to express our sincere thanks to you and your team! Without their commitment, the successful completion of the project would not have been possible.
We look forward to working with you in partnership in the future!

Dr. Hans-Georg Feldmeier – CEO Dermapharm SE
Dr. Sierk Poetting – CFO and COO BioNTech SE